Download PDF

1. Company Snapshot

1.a. Company Description

Glanbia plc operates as a nutrition company worldwide.The company manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, online, and gyms, as well the food, drug, mass, and club channels.It engages in the manufacture and sale of cheese, dairy, and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes.


In addition, the company engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses.It operates a portfolio of brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT brands.Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Show Full description

1.b. Last Insights on GLB

Glanbia plc's recent performance was positively driven by the divestiture of its online sports-nutrition business, Body & Fit, which allows the company to focus on its core operations. Additionally, the company is well-positioned in the growing market for egg replacers, with a projected CAGR of 7.58% from 2025 to 2030. Glanbia's presence in this market, alongside key players like Cargill and Kerry Group, is expected to drive growth. However, concerns over governance and transparency have been raised by the Institute for Governance & Markets.

1.c. Company Highlights

2. Glanbia's 2025 Earnings: A Mixed Bag

Glanbia's 2025 financial performance was marked by a 2.3% increase in revenue to $3.95 billion on a constant currency basis, driven by a 3.7% rise in volumes. However, the company's pre-exceptional EBITDA declined by 9.4% to $499.1 million, primarily due to higher whey input costs. Adjusted earnings per share came in at $1.3493, down 2.4% on a constant currency basis. The EBITDA margin contracted by 170 basis points to 12.6%. The actual EPS for the year was $0.612, beating estimates of $0.593.

Publication Date: Feb -26

📋 Highlights
  • Revenue & Volume Growth:: Glanbia achieved $3.95B revenue (up 2.3% constant currency) with 3.7% volume growth, driven by strong demand in protein brands and dairy pricing.
  • Segment Performance:: Health & Nutrition led with 6.8% revenue growth (7.4% volume increase) and 18.4% EBITDA margin, up 80 bps despite 0.6% price decline.
  • EBITDA Decline:: Pre-exceptional EBITDA fell 9.4% to $499.1M due to higher whey input costs, with group EBITDA margin dropping 170 bps to 12.6%.
  • Shareholder Returns:: Returned EUR 399.5M to shareholders (EUR 197M buybacks + EUR 102.5M dividends) and authorized an additional EUR 100M buyback in 2026.
  • Transformation Program:: $60M+ annual cost savings by 2027, with 50% reinvested for growth, including $51M in strategic capex for capacity and IT upgrades.

Segmental Performance

The Performance Nutrition segment delivered like-for-like revenue growth of 4.5%, driven by strong category growth and innovation, with Optimum Nutrition, the largest brand, posting 6.4% like-for-like revenue growth. Health & Nutrition reported a robust performance with 6.8% like-for-like revenue growth, driven by a 7.4% increase in volume. Dairy Nutrition also saw a 5% like-for-like revenue growth, driven by a 4.2% increase in volume.

Transformation Program and Guidance

Glanbia made significant progress on its group-wide transformation program, expected to generate annual cost savings of at least $60 million by 2027. The company expects Performance Nutrition like-for-like organic revenue growth to be between 5% and 7% in 2026, driven by pricing. For the medium term, Glanbia targets annual organic revenue growth of 5-7% in Performance Nutrition and 4-6% in Health & Nutrition.

Valuation and Outlook

With a P/E Ratio of 42.43 and an EV/EBITDA of 14.72, the market appears to be pricing in significant growth expectations. The company's guidance for 2026 suggests that it is on track to deliver on its medium-term targets. As Hugh McGuire noted, "we are moving at pace as outlined in our Capital Markets Day," reinforcing Glanbia's conviction for growth. Analysts estimate next year's revenue growth at 3.8%, which is slightly below the company's medium-term targets.

3. NewsRoom

Card image cap

Glanbia PLC (GLAPF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Cost ...

Feb -25

Source:

Card image cap

Food Supplements Market Report 2026-2035: A $409.96 Billion Industry by 2030 with Archer-Daniels-Midland, Bayer, Glanbia, Herbalife Nutrition, and Amway Leading

Feb -20

Source:

Card image cap

Weight Management Supplements Market Report 2026: A $15+ Billion Market by 2030 Featuring Leading Players - Nestle, Abbott Laboratories, GSK, Glanbia, Herbalife Nutrition, and Amway - Forecast to 2035

Feb -20

Source:

Card image cap

Looking At The Narrative For Glanbia (ISE:GL9) After Subtle Shifts In Street Targets

Feb -05

Source:

Card image cap

A Look At Glanbia (ISE:GL9) Valuation After Recent Share Price Strength

Feb -05

Source:

Card image cap

Whey Protein Products Global Market Research and Forecast Report 2025-2030, Profiles of Major Players - Glanbia PLC, Arla Foods amba, Fonterra Co-operative Group, Lactalis and Hilmar Cheese

Feb -04

Source:

Card image cap

Cheese Forecast Report 2025: A $317.61 Billion Market by 2033 Featuring Sargento Foods, Glanbia, Lactalis Int'l, Saputo, Bel Brands, FrieslandCampina, Daiya Foods, Kite Hill, Arla Foods, Fonterra

Jan -28

Source:

Card image cap

Herbal Supplements Market Trends, Business Opportunities and Growth Outlook 2025-2030 Featuring Glanbia, Archer Daniels Midland, Nutramarks and Other Key Players

Dec -05

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (8.95%)

6. Segments

Apparel, Footwear and Hardgoods

Expected Growth: 8.95%

Glanbia's 8.95% growth in Apparel, Footwear, and Hardgoods is driven by increasing demand for athleisure wear, expansion into new markets, and strategic partnerships. Additionally, the company's focus on sustainability, innovative products, and e-commerce growth have contributed to its success.

7. Detailed Products

Dairy Ireland

Glanbia's Dairy Ireland segment operates in the Irish dairy market, producing a range of dairy products including cheese, butter, and milk powder.

Dairy UK

Glanbia's Dairy UK segment operates in the UK dairy market, producing a range of dairy products including cheese, butter, and milk powder.

Nutritionals

Glanbia's Nutritionals segment produces a range of nutritional products including whey protein, lactoferrin, and other dairy-based ingredients.

Performance Nutrition

Glanbia's Performance Nutrition segment produces a range of sports nutrition products including protein powders, bars, and supplements.

Joint Ventures

Glanbia's Joint Ventures segment includes partnerships with other companies to produce and market dairy products.

8. Glanbia plc's Porter Forces

Forces Ranking

Threat Of Substitutes

Glanbia plc operates in the nutrition industry, which has a moderate threat of substitutes. While there are some substitutes available, they are not a significant threat to the company's business.

Bargaining Power Of Customers

Glanbia plc has a diverse customer base, which reduces the bargaining power of individual customers. Additionally, the company's products are often customized to meet specific customer needs, making it difficult for customers to switch to alternative suppliers.

Bargaining Power Of Suppliers

Glanbia plc relies on a network of suppliers for raw materials and ingredients. While the company has some bargaining power due to its size and scale, suppliers also have some bargaining power due to the specialized nature of some of the ingredients used in the company's products.

Threat Of New Entrants

The nutrition industry has high barriers to entry, including significant capital requirements and regulatory hurdles. Additionally, Glanbia plc has a strong brand presence and established distribution networks, making it difficult for new entrants to gain traction.

Intensity Of Rivalry

The nutrition industry is highly competitive, with several large players competing for market share. Glanbia plc faces intense competition from companies such as Abbott Nutrition, Nestle, and Danone, which can lead to pricing pressure and reduced margins.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 24.24%
Debt Cost 3.95%
Equity Weight 75.76%
Equity Cost 6.72%
WACC 6.05%
Leverage 32.00%

11. Quality Control: Glanbia plc passed 7 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Nomad Foods

A-Score: 5.7/10

Value: 8.7

Growth: 7.4

Quality: 4.8

Yield: 5.6

Momentum: 1.0

Volatility: 6.3

1-Year Total Return ->

View Full Report
Stock-Card
Lerøy Seafood

A-Score: 5.1/10

Value: 5.2

Growth: 4.6

Quality: 4.2

Yield: 6.2

Momentum: 3.0

Volatility: 7.3

1-Year Total Return ->

View Full Report
Stock-Card
Emmi

A-Score: 4.9/10

Value: 4.6

Growth: 4.8

Quality: 5.0

Yield: 3.1

Momentum: 2.5

Volatility: 9.7

1-Year Total Return ->

View Full Report
Stock-Card
Glanbia

A-Score: 3.9/10

Value: 4.0

Growth: 5.0

Quality: 4.5

Yield: 4.4

Momentum: 5.0

Volatility: 0.7

1-Year Total Return ->

View Full Report
Stock-Card
Lotus Bakeries

A-Score: 3.8/10

Value: 0.7

Growth: 7.7

Quality: 6.7

Yield: 1.2

Momentum: 0.5

Volatility: 6.3

1-Year Total Return ->

View Full Report
Stock-Card
Tate Lyle

A-Score: 3.7/10

Value: 4.1

Growth: 1.1

Quality: 2.3

Yield: 8.8

Momentum: 0.0

Volatility: 6.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

0.17$

Current Price

0.17$

Potential

-0.00%

Expected Cash-Flows